Company news

Adaptive Biotechnologies Corporation news in 2026

Adaptive Biotechnologies Corporation's news releases, calls and decks from 2026, newest first.

View company

Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results

November 4, 2026

Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026

October 14, 2026

Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure

September 25, 2026

Adaptive Biotechnologies Announces Update to NCCN Guidelines for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ

September 18, 2026

Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®

September 17, 2026

Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

September 1, 2026

Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)

August 4, 2026

Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results

July 29, 2026

Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026

July 9, 2026

Adaptive Biotechnologies: Imviva Biotech Receives FDA IDE Authorization for clonoSEQ® Assay in TENACITY-01 Clinical Trial

June 30, 2026

Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering

June 17, 2026

Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses

June 15, 2026

Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering

June 15, 2026

At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research

May 29, 2026

At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research

May 29, 2026

Adaptive Biotechnologies Reports First Quarter 2026 Financial Results

May 5, 2026

Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026

April 14, 2026

Slingshot Biosciences Appoints Jim Snook as Senior Vice President, Global Sales

March 5, 2026

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results

February 5, 2026

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

January 27, 2026

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

January 22, 2026

Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results

January 12, 2026

Calls in 2026

Decks in 2026